| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1111/J.1398-9995.1998.TB04930.X |
| P698 | PubMed publication ID | 9695884 |
| P433 | issue | 44 Suppl | |
| P921 | main subject | therapeutic vaccine | Q105212712 |
| immunotherapy | Q1427096 | ||
| P304 | page(s) | 1-42 | |
| P577 | publication date | 1998-01-01 | |
| P1433 | published in | Allergy | Q2699825 |
| P1476 | title | Allergen immunotherapy: therapeutic vaccines for allergic diseases. Geneva: January 27-29 1997 | |
| P478 | volume | 53 |
| Q37763296 | 2003 canadian asthma consensus guidelines executive summary |
| Q53006587 | A novel adjuvant complex, tyrosine-MPL, for prophylactic and therapeutic vaccines. |
| Q73454036 | A sensitive two-site enzyme-linked immunosorbent assay for measurement of the major Alternaria alternata allergen Alt a 1 |
| Q57449177 | Adequate doses of autoantigen administered using the appropriate route may create tolerance and stop autoimmunity |
| Q54450391 | Allergen immunotherapy: a long-term perspective. |
| Q24243115 | Allergen injection immunotherapy for seasonal allergic rhinitis |
| Q34321339 | Appropriate and inappropriate use of immunotherapy |
| Q55403212 | Chinese Society of Allergy Guidelines for Diagnosis and Treatment of Allergic Rhinitis. |
| Q40190644 | Dose adjustment practices among allergists for local reactions to immunotherapy |
| Q42657579 | Economic evaluation of sublingual vs subcutaneous allergen immunotherapy |
| Q74237112 | Effectiveness of specific immunotherapy in the treatment of asthma: a meta-analysis of prospective, randomized, double-blind, placebo-controlled studies |
| Q43515187 | Efficacy and safety of specific immunotherapy with a high-dose sublingual grass pollen preparation: a double-blind, placebo-controlled trial |
| Q39667736 | Efficacy and tolerability of short-term specific immunotherapy with pollen allergoids adjuvanted by monophosphoryl lipid A (MPL) for children and adolescents |
| Q34561153 | Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials |
| Q34987271 | From allergen structure to new forms of allergen-specific immunotherapy |
| Q64914480 | Immunotherapy for Cat Allergies: A Potential Strategy to Scratch Back. |
| Q33194695 | Mucosal co-application of lactic acid bacteria and allergen induces counter-regulatory immune responses in a murine model of birch pollen allergy |
| Q40581768 | Natural history of hay fever and pollen sensitization, and doctors' diagnosis of hay fever and pollen asthma in German schoolchildren |
| Q34134867 | New trends in immunotherapy to prevent atopic diseases |
| Q33860037 | Once-daily inhaled corticosteroids in children with asthma: dry powder inhalers |
| Q37039551 | Orthologous Allergens and Diagnostic Utility of Major Allergen Alt a 1. |
| Q40062882 | Patient perceptions regarding local reactions from allergen immunotherapy injections |
| Q73640664 | Pediatric allergology in Austria |
| Q73297911 | Preseasonal local allergoid immunotherapy to grass pollen in children: a double-blind, placebo-controlled, randomized trial |
| Q34374552 | Role of IL-10 in allergen-specific immunotherapy and normal response to allergens |
| Q81330871 | Safety of sublingual grass pollen immunotherapy after anaphylaxis |
| Q39644618 | Single-course specific immunotherapy with mixed pollen allergoids: results of a multi-centre study |
| Q35007608 | Skin prick testing and immunotherapy in nasobronchial allergy: our experience |
| Q24235206 | Specific immunotherapy for latex allergy |
| Q43880229 | Standardisation of glutaraldehyde-modified tyrosine-adsorbed tree pollen vaccines containing the Th1-inducing adjuvant, monophosphoryl lipid A (MPL). |
| Q33577679 | Strategies of mucosal immunotherapy for allergic diseases |
| Q36255673 | Summary of recommendations from the Canadian Asthma Consensus guidelines, 2003. |
| Q34561901 | The potential of peptide immunotherapy in allergy and asthma |
| Q35677872 | The rate of systemic reactions to immunotherapy injections is the same whether or not the dose is reduced after a local reaction |
| Q33704295 | The role of allergen-specific T cells in the allergic immune response: relevance to allergy vaccination |
| Q33988215 | The role of allergy in childhood asthma |
| Q37408019 | The role of immunomodulation therapy in autoimmune diabetes |
| Q42716940 | Trends in Specific Immunotherapy for Allergic Rhinitis: A Survey of Chinese ENT Specialists |
| Q73906796 | Ultrarush SIT in venom allergy |
| Q79175039 | [Immunotherapy in asthma] |
Search more.